GreatNorthCollective/greatnorth-canada-federal-laws-text huggingface dataset:
Cannabis Regulations — 27
27 Section 179 of the Regulations is replaced by the following: Sale and distribution — no emergency 178.1 (1) Subject to section 174, a pharmacist may, in circumstances other than an emergency, sell or distribute a prescription drug to another pharmacist, in accordance with a written order that is signed and dated by the other pharmacist, if (a) they do so for the purpose of fulfilling a prescription received by the other pharmacist; or (b) they are ceasing to practise at the pharmacy where the drug is sold or distributed. Signature (2) Before selling or distributing the prescription drug, the pharmacist receiving the order must verify the signature if it is unknown to them. Record keeping (3) The pharmacist who sells or distributes the prescription drug and the pharmacist to whom it is sold or distributed must each retain a record of the following information: (a) in the case of the pharmacist who sells or distributes the drug, (i) their name, (ii) the name and address of the pharmacist to whom they sell or distribute the drug, (iii) the brand name, quantity and form of the drug, and (iv) the date of the sale or distribution of the drug; and (b) in the case of the pharmacist to whom the drug is sold or distributed, (i) their name, (ii) the name and address of the pharmacist who sells or distributes the drug to them, (iii) the brand name, quantity and form of the drug, and (iv) the date on which the drug is received. Retention period 179 (1) Subject to subsections (2) and (3), a pharmacist must ensure that the records that the pharmacist is required to retain under this Part are retained for at least two years after the day on which they are prepared. Ceasing to practise (2) If the pharmacist ceases to practise at the pharmacy where the records are prepared, the pharmacist who is responsible for the operations of that pharmacy must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period. Ceasing operations (3) If the pharmacy where the pharmacist practises ceases its operations, the person responsible for those operations on the date those operations cease must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period.
Cannabis Regulations — 178.1
Sale and distribution — no emergency 178.1 (1) Subject to section 174, a pharmacist may, in circumstances other than an emergency, sell or distribute a prescription drug to another pharmacist, in accordance with a written order that is signed and dated by the other pharmacist, if (a) they do so for the purpose of fulfilling a prescription received by the other pharmacist; or (b) they are ceasing to practise at the pharmacy where the drug is sold or distributed. Signature (2) Before selling or distributing the prescription drug, the pharmacist receiving the order must verify the signature if it is unknown to them. Record keeping (3) The pharmacist who sells or distributes the prescription drug and the pharmacist to whom it is sold or distributed must each retain a record of the following information: (a) in the case of the pharmacist who sells or distributes the drug, (i) their name, (ii) the name and address of the pharmacist to whom they sell or distribute the drug, (iii) the brand name, quantity and form of the drug, and (iv) the date of the sale or distribution of the drug; and (b) in the case of the pharmacist to whom the drug is sold or distributed, (i) their name, (ii) the name and address of the pharmacist who sells or distributes the drug to them, (iii) the brand name, quantity and form of the drug, and (iv) the date on which the drug is received.
Cannabis Regulations — 179
Retention period 179 (1) Subject to subsections (2) and (3), a pharmacist must ensure that the records that the pharmacist is required to retain under this Part are retained for at least two years after the day on which they are prepared. Ceasing to practise (2) If the pharmacist ceases to practise at the pharmacy where the records are prepared, the pharmacist who is responsible for the operations of that pharmacy must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period. Ceasing operations (3) If the pharmacy where the pharmacist practises ceases its operations, the person responsible for those operations on the date those operations cease must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period.
Cannabis Regulations — 28
28 Paragraph 181(4)(a) of the Regulations is replaced by the following: (a) has contravened section 171 , subsection 172 (1) or (2), section 174 , 175 or 176 or subsection 178 (1) or 178.1 (1) or (2);
Cannabis Regulations — 29
29 (1) The portion of subsection 184(1) of the French version of the Regulations before paragraph (a) is replaced by the following: Retour et destruction 184 (1) Le praticien est autorisé à vendre ou à distribuer une drogue contenant du cannabis aux personnes ci-après conformément à une commande écrite : (2) Paragraph 184(2)(a) of the Regulations is replaced by the following: (a) the quantity and strength per unit of the drug as well as its proper name or common name or, in the case of a prescription drug, its brand name; and (3) Paragraph 184(3)(a) of the Regulations is replaced by the following: (a) its form, quantity and strength per unit as well as its proper name or common name or, in the case of a prescription drug, its brand name;
Cannabis Regulations — 184
Retour et destruction 184 (1) Le praticien est autorisé à vendre ou à distribuer une drogue contenant du cannabis aux personnes ci-après conformément à une commande écrite :
Cannabis Regulations — 30
30 The portion of section 186 of the Regulations before paragraph (a) is replaced by the following: Record keeping 186 A practitioner who sells or distributes a drug containing cannabis to an individual for self-administration or for administration to an animal must, whether or not the practitioner charges for the drug, retain a record showing the drug’s proper name or common name — or, in the case of a prescription drug, its brand name — and the quantity of the drug sold or distributed, as well as the name and address of the individual to whom and the date on which it was sold or distributed, if the quantity of the drug exceeds
Cannabis Regulations — 186
Record keeping 186 A practitioner who sells or distributes a drug containing cannabis to an individual for self-administration or for administration to an animal must, whether or not the practitioner charges for the drug, retain a record showing the drug’s proper name or common name — or, in the case of a prescription drug, its brand name — and the quantity of the drug sold or distributed, as well as the name and address of the individual to whom and the date on which it was sold or distributed, if the quantity of the drug exceeds
Cannabis Regulations — 31
31 Section 187 of the Regulations is replaced by the following: Retention period 187 (1) Subject to subsections (2) and (3), a practitioner must ensure that the records that the practitioner is required to retain under this Part are retained for at least two years after the day on which they are prepared. Ceasing to practise (2) If the practitioner ceases to practise at the place where the records are prepared, the practitioner who is responsible for the operations of that place must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period. Ceasing operations (3) If the place where the practitioner practises ceases its operations, the person responsible for those operations on the date those operations cease must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period.
Cannabis Regulations — 187
Retention period 187 (1) Subject to subsections (2) and (3), a practitioner must ensure that the records that the practitioner is required to retain under this Part are retained for at least two years after the day on which they are prepared. Ceasing to practise (2) If the practitioner ceases to practise at the place where the records are prepared, the practitioner who is responsible for the operations of that place must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period. Ceasing operations (3) If the place where the practitioner practises ceases its operations, the person responsible for those operations on the date those operations cease must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period.
Cannabis Regulations — 32
32 (1) The portion of paragraph 189(1)(a) of the Regulations before subparagraph (i) is replaced by the following: (a) the following persons must not sell or distribute any drug containing cannabis to the practitioner: (2) Paragraph 189(2)(e) of the Regulations is replaced by the following: (e) the applicable provincial professional regulatory authority for the province in which the practitioner is entitled to practise; and (3) Paragraphs 189(4)(b) to (d) of the Regulations are replaced by the following: (b) has, on more than one occasion, self-administered a drug containing cannabis under a self-directed prescription or order or, in the absence of a prescription or order, contrary to accepted professional practice; (c) has, on more than one occasion, distributed or administered a drug containing cannabis to their spouse, common-law partner, parent or child, including a child adopted in fact, contrary to accepted professional practice; or (d) is unable to account for the quantity of drugs containing cannabis for which the practitioner was responsible under this Part or Part 9. (4) Subparagraph 189(5)(c)(iii) of the Regulations is replaced by the following: (iii) whether the actions of the practitioner pose a significant risk to public health or public safety, including the risk of any drug containing cannabis being diverted to an illicit market or activity.
Cannabis Regulations — 33
33 (1) Subparagraph 191(a)(i) of the Regulations is replaced by the following: (i) the brand name and quantity of the drug, (2) The portion of paragraph 191(b) of the Regulations before subparagraph (ii) is replaced by the following: (b) with respect to a prescription drug that is sold, distributed or administered by the hospital, (i) the name of the patient for whom, or the animal for which, the drug was sold, distributed or administered,
Cannabis Regulations — 34
34 The portion of section 192 of the Regulations before paragraph (a) is replaced by the following: Security obligations 192 An individual in charge of a hospital must, with respect to a prescription drug for which the hospital is responsible,
Cannabis Regulations — 192
Security obligations 192 An individual in charge of a hospital must, with respect to a prescription drug for which the hospital is responsible,
Cannabis Regulations — 35
35 (1) The portion of subsection 193(2) of the Regulations before paragraph (a) is replaced by the following: Inpatients and outpatients (2) The individual in charge of a hospital may authorize the sale, distribution or administration of a prescription drug only in accordance with a prescription, signed and dated by a practitioner, and only (2) Paragraph 193(2)(a) of the English version of the Regulations is replaced by the following: (a) in the case of administration, to an individual or an animal under treatment as an inpatient or outpatient of the hospital; or (3) The portion of subsection 193(3) of the Regulations before paragraph (a) is replaced by the following: Distribution or sale in an emergency (3) Despite subsection (2), for emergency purposes, the individual in charge of a hospital may authorize the sale or distribution of a prescription drug to (4) Subparagraphs 193(3)(a)(i) and (ii) of the Regulations are replaced by the following: (i) the drug is sold or distributed in accordance with a written order signed and dated by a pharmacist or practitioner authorized by the individual in charge of the other hospital to sign the order, and (ii) the person that sells or distributes the drug verifies the signature of the pharmacist or practitioner, if that signature is unknown to the person; (5) Subparagraphs 193(3)(b)(i) and (ii) of the Regulations are replaced by the following: (i) the drug is sold or distributed in accordance with a written order signed and dated by a pharmacist or practitioner who is authorized by the individual in charge of the other hospital to sign the order, and (ii) the person that sells or distributes the drug verifies the signature of the pharmacist or practitioner, if that signature is unknown to the person; and (6) Paragraph 193(3)(c) of the English version of the Regulations is replaced by the following: (c) an individual who is exempt under section 140 of the Act with respect to the drug and who is employed in a research laboratory in the hospital for the purpose of research.
Cannabis Regulations — 36
36 (1) The portion of subsection 194(1) of the Regulations before paragraph (a) is replaced by the following: Return and destruction 194 (1) Despite subsection 193(2), the individual in charge of a hospital may authorize the sale or distribution of a prescription drug, in accordance with a written order, to (2) Paragraph 194(2)(a) of the Regulations is replaced by the following: (a) the brand name, quantity and strength per unit of the drug; and (3) Paragraph 194(3)(b) of the English version of the Regulations is replaced by the following: (b) the name and address of the person to which it was sold or distributed; and
Cannabis Regulations — 194
Return and destruction 194 (1) Despite subsection 193(2), the individual in charge of a hospital may authorize the sale or distribution of a prescription drug, in accordance with a written order, to
Cannabis Regulations — 37
, its drug identification number, (iv) the form, quantity and strength per unit of the drug, and (v) the daily dose authorized by the health care provider; and (d) the imported quantity of the drug does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label. Exportation 195.5 On departing Canada, an individual may export a drug containing cannabis that is in their actual possession or that forms part of their baggage if (a) the individual is exporting the drug (i) for their own use, (ii) for the use and on behalf of an accompanying individual, or (iii) for administration to an animal for which the individual is responsible and that is accompanying the individual; (b) the drug is in a container obtained from a health care provider and carrying a label on which the following information appears: (i) the name of the individual for whom, or the animal for which, the drug was lawfully obtained, (ii) the name of the health care provider who authorized the drug to be obtained, (iii) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and, if any, its drug identification number, (iv) the form, quantity and strength per unit of the drug, and (v) the daily dose authorized by the health care provider; and (c) the exported quantity of the drug does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label.
Cannabis Regulations — 195
Retention period 195 (1) Subject to subsections (2) and (3), an individual in charge of a hospital must ensure that the records that the individual is required to retain under this Part are retained for at least two years after the day on which they are prepared. Ceasing to act (2) If the individual in charge of the hospital ceases to act in that capacity at the hospital where the records are prepared, the individual who replaces that individual must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period. Ceasing operations (3) If the hospital ceases its operations, the person responsible for those operations on the date those operations cease must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period.
Cannabis Regulations — 195.1
Record keeping — drug received 195.1 A licensed dealer that receives a drug containing cannabis must enter the following in a record retained for such purposes: (a) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and drug identification number; (b) the form, quantity and strength per unit of the drug received; (c) the name and address of the person from which the drug was received; and (d) the date of receipt.
Cannabis Regulations — 195.2
Sale or distribution for destruction 195.2 (1) A licensed dealer, other than a licensed dealer specialized in destruction, may sell or distribute a drug containing cannabis, in accordance with a written order, to a licensed dealer specialized in destruction if the drug is sold or distributed for the purpose of its destruction. Written order (2) The written order must contain (a) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and drug identification number; (b) the quantity and strength per unit of the drug; and (c) an attestation that states that the sole purpose of the order is the destruction of the drug and that is signed and dated by, or on behalf of, the licensed dealer specialized in destruction. Record keeping (3) The licensed dealer referred to in subsection (1) that sells or distributes the drug must prepare a record that sets out (a) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and drug identification number; (b) the form, quantity and strength per unit of the drug; (c) the name and address of the person to which it was sold or distributed; and (d) the date on which it was sold or distributed.
Cannabis Regulations — 195.3
Retention period 195.3 The licensed dealer must retain the records referred to in section 195.1 and subsection 195.2 (3) for at least two years after the day on which they are prepared.
Cannabis Regulations — 195.4
Importation 195.4 On entering Canada, an individual may import a drug containing cannabis that is in their actual possession or that forms part of their baggage if (a) the individual is importing the drug (i) for their own use, (ii) for the use and on behalf of an accompanying individual, or (iii) for administration to an animal for which the individual is responsible and that is accompanying the individual; (b) the drug is declared to a customs officer at the port of entry into Canada; (c) the drug is in a container obtained from a health care provider and carrying a label on which the following information appears: (i) the name of the individual for whom, or the animal for which, the drug was lawfully obtained, (ii) the name of the health care provider who authorized the drug to be obtained, (iii) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and, if any, its drug identification number, (iv) the form, quantity and strength per unit of the drug, and (v) the daily dose authorized by the health care provider; and (d) the imported quantity of the drug does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label.
Cannabis Regulations — 195.5
Exportation 195.5 On departing Canada, an individual may export a drug containing cannabis that is in their actual possession or that forms part of their baggage if (a) the individual is exporting the drug (i) for their own use, (ii) for the use and on behalf of an accompanying individual, or (iii) for administration to an animal for which the individual is responsible and that is accompanying the individual; (b) the drug is in a container obtained from a health care provider and carrying a label on which the following information appears: (i) the name of the individual for whom, or the animal for which, the drug was lawfully obtained, (ii) the name of the health care provider who authorized the drug to be obtained, (iii) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and, if any, its drug identification number, (iv) the form, quantity and strength per unit of the drug, and (v) the daily dose authorized by the health care provider; and (c) the exported quantity of the drug does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label.
Cannabis Regulations — 38
38 Section 196 of the Regulations is repealed.
Cannabis Regulations — 39
39 Sections 198 and 199 of the Regulations are replaced by the following: Exemption — section 21 of Act 198 A person is exempt from the application of section 21 of the Act if they display, refer to or otherwise use the brand name of a combination product, or the name of the holder of the drug identification number for the product, directly or indirectly in a promotion that is used in the sponsorship of a person, entity, event, activity or facility. Exemption — section 22 of Act 199 A person is exempt from the application of section 22 of the Act if they display on a facility, as part of the name of the facility or otherwise, if the facility is used for a sports or cultural event or activity, the brand name of a combination product or the name of the holder of the drug identification number for the product.
Cannabis Regulations — 198
Exemption — section 21 of Act 198 A person is exempt from the application of section 21 of the Act if they display, refer to or otherwise use the brand name of a combination product, or the name of the holder of the drug identification number for the product, directly or indirectly in a promotion that is used in the sponsorship of a person, entity, event, activity or facility.
Cannabis Regulations — 199
Exemption — section 22 of Act 199 A person is exempt from the application of section 22 of the Act if they display on a facility, as part of the name of the facility or otherwise, if the facility is used for a sports or cultural event or activity, the brand name of a combination product or the name of the holder of the drug identification number for the product.
Cannabis Regulations — 40
40 Subparagraphs 205(c)(iv) and (v) of the Regulations are replaced by the following: (iv) in the case of a drug containing cannabis, other than a prescription drug, the proper name or common name of the drug, (v) in the case of a prescription drug, the brand name of the drug and its identification number, (vi) the quantity of the cannabis, and (vii) the percentages of THC w/w and CBD w/w of the cannabis, except in the case of cannabis plants and cannabis plant seeds;
Cannabis Regulations — 41
41 Subparagraphs 209(c)(iv) and (v) of the Regulations are replaced by the following: (iv) in the case of a drug containing cannabis, other than a prescription drug, the proper name or common name of the drug, (v) in the case of a prescription drug, the brand name of the drug and its drug identification number, (vi) the quantity of the cannabis, and (vii) the percentages of THC w/w and CBD w/w of the cannabis, except in the case of cannabis plants and cannabis plant seeds.
Cannabis Regulations — 42
42 Subparagraphs 214(c)(iv) and (v) of the Regulations are replaced by the following: (iv) in the case of a drug containing cannabis, other than a prescription drug, the proper name or common name of the drug, (v) in the case of a prescription drug, the brand name of the drug and its drug identification number, (vi) the quantity of the cannabis, and (vii) the percentages of THC w/w and CBD w/w of the cannabis, except in the case of cannabis plants and cannabis plant seeds;